2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

. Author manuscript; available in PMC: 2017 Sep 21.

Published in final edited form as: Circulation. 2016 Nov 13;135(12):e686–e725. doi: 10.1161/CIR.0000000000000470


Recommendations for Endovascular Revascularization for Claudication

COR	LOE	Recommendations

I	A	Endovascular procedures are effective as a revascularization option for patients with lifestyle-limiting claudication and hemodynamically significant aortoiliac occlusive disease.^{13,25,26,190,194,196,201}

IIa	B-R	Endovascular procedures are reasonable as a revascularization option for patients with lifestyle-limiting claudication and hemodynamically significant femoropopliteal disease.^{190,197–200,205,206}

IIb	C-LD	The usefulness of endovascular procedures as a revascularization option for patients with claudication due to isolated infrapopliteal artery disease is unknown.^211–213

III: Harm	B-NR	Endovascular procedures should not be performed in patients with PAD solely to prevent progression to CLI.^{186–189,214–216}